Rhoen-Klinikum AG (RHK)

  13.10
   
  • Change Today:
     0.20
  • 52 Week High:  15.90
  • 52 Week Low:  11.30
  • Currency: Euro
  • Shares Issued: 66.96m
  • Volume: 3,050
  • Market Cap:  877.20m
Select chart: 1 week | 1 month | 3 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,661.87 49.23 64.67¢ 20.3 n/a -11% 21.50¢ 0.0%
31-Dec-26 1,727.91 58.99 75.67¢ 17.3 1.0 +17% 21.33¢ 0.0%
31-Dec-27 1,880.00 68.00 85.00¢ 15.4 1.2 +12% 15.00¢ 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
31-Dec-25  24.82 0.53
31-Dec-26  25.80 0.51
31-Dec-27  28.08 0.47

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ( m)
31-Dec-2026 1,728 1,728 n/a n/a n/a 1,710
31-Dec-2027 1,880 1,880 n/a n/a n/a n/a
 
Earnings
31-Dec-2026 75.67¢ 75.67¢ n/a n/a n/a 71.00¢
31-Dec-2027 85.00¢ 85.00¢ n/a n/a n/a n/a
 
Dividend
31-Dec-2026 21.33¢ 21.33¢ n/a n/a n/a 15.00¢
31-Dec-2027 15.00¢ 15.00¢ n/a n/a n/a n/a
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 1 1 1 1 0 0
Neutral 2 2 2 2 0 2
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 3 3 3 3 0 2
 
Average Rec 5.83 5.83 5.83 5.83 n/a 5.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

RHK Market Data

Currency Euro
Share Price   13.10
Change Today   0.20
% Change 1.55 %
52 Week High  15.90
52 Week Low  11.30
Volume 3,050
Shares Issued 66.96m
Market Cap  877.20m

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 3
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page